Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. It has not gone away. Instead, the challenges of AMR now need to be seen through the lens of changing clinical care due to COVID-19.
Here we list some of the online resources, opinions pieces and publications available on this topic, compiled by Gwen Knight. For more insights from Gwen on this subject, read her article Thinking about AMR again?
- Issra Bulgasim & Adam Roberts at the Liverpool School for Tropical Medicine have compiled details of publications and online resources on secondary infections, antibiotic chemotherapy and antibiotic resistance in the context of COVID-19.
- The British Society for Antimicrobial Chemotherapy and JAC-Antimicrobial Resistance have developed a COVID-19 Resource Hub committed to “signposting vital information and latest guidance from health bodies, academic publications and other professional societies”.
- Opinion pieces from key AMR organisations: ReAct, JPIAMR, SEDRIC, CIDRAP, AMR-Insights, GAVI, CARB-X.
- COVID-19, superinfections and antimicrobial development: What can we expect?
Cornelius J Clancy, MD, M Hong Nguyen, MD Clinical Infectious Diseases, ciaa524. 01 May 2020
- The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance.
Aimee K Murray. Opinion Article Frontiers in Microbiology. 13 May 2020.
- How COVID-19 is accelerating the threat of antimicrobial resistance.
BMJ 2020; 369. 18 May 2020
- COVID-19 and the potential long-term impact on antimicrobial resistance.
Timothy M Rawson, Luke S P Moore, Enrique Castro-Sanchez, Esmita Charani, Frances Davies, Giovanni Satta, Matthew J Ellington, Alison H Holmes. Journal of Antimicrobial Chemotherapy, dkaa194. 20 May 202
- Antimicrobial resistance in the age of COVID-19.
Editorial: Nature Microbiology. 5, 779. 20 May 2020
- Debate on whether AMR will increase or decrease due to COVID-19.
JAC - Antimicrobial Resistance. Volume 2, issue 3.